These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34265421)

  • 1. Design and synthesis of novel 5-alkynyl pyrimidine nucleosides derivatives: Influence of C-6-substituent on antituberculosis activity.
    Volov AN; Volov NA; Platonova YB
    Bioorg Med Chem Lett; 2021 Sep; 48():128261. PubMed ID: 34265421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthesis and antituberculosis activity of 5-alkynyl uracil derivatives.
    Platonova YB; Volov AN; Tomilova LG
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127351. PubMed ID: 32631549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria.
    Rai D; Johar M; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2005 Nov; 48(22):7012-7. PubMed ID: 16250660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides.
    Johar M; Manning T; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2005 Dec; 13(24):6663-71. PubMed ID: 16140016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.
    Shmalenyuk ER; Chernousova LN; Karpenko IL; Kochetkov SN; Smirnova TG; Andreevskaya SN; Chizhov AO; Efremenkova OV; Alexandrova LA
    Bioorg Med Chem; 2013 Sep; 21(17):4874-84. PubMed ID: 23891229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
    Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
    Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
    Srivastav NC; Shakya N; Bhavanam S; Agrawal A; Tse C; Desroches N; Kunimoto DY; Kumar R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1091-4. PubMed ID: 22178557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity.
    Raphoko LA; Lekgau K; Lebepe CM; Leboho TC; Matsebatlela TM; Nxumalo W
    Bioorg Med Chem Lett; 2021 Mar; 35():127784. PubMed ID: 33422606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
    de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D
    Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring.
    Termentzi A; Khouri I; Gaslonde T; Prado S; Saint-Joanis B; Bardou F; Amanatiadou EP; Vizirianakis IS; Kordulakova J; Jackson M; Brosch R; Janin YL; Daffé M; Tillequin F; Michel S
    Eur J Med Chem; 2010 Dec; 45(12):5833-47. PubMed ID: 20961671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antitubercular evaluation of novel 2-substituted-3H-benzofuro benzofurans via palladium-copper catalysed Sonagashira coupling reaction.
    Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5393-6. PubMed ID: 23953191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
    Abhale YK; Shinde A; Shelke M; Nawale L; Sarkar D; Mhaske PC
    Bioorg Chem; 2021 Oct; 115():105192. PubMed ID: 34314920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
    Subhedar DD; Shaikh MH; Arkile MA; Yeware A; Sarkar D; Shingate BB
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1704-8. PubMed ID: 26927426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.